Snail interacts with hPLSCR1 promoter and down regulates its expression in IMR-32

•Putative TFs binding sites for AML-1, Sox-5 and Snail within hPLSCR1 promoter.•−1118CAGGTG−1123 is the Snail binding site in hPLSCR1 promoter.•Interaction of Snail with endogenous hPLSCR1 promoter confirmed by ChIP assay. Human phospholipid scramblase 1 (hPLSCR1) is a proapoptotic protein whose exp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2014-07, Vol.450 (1), p.172-177
Hauptverfasser: Francis, Vincent Gerard, Padmanabhan, Purnima, Gummadi, Sathyanarayana N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Putative TFs binding sites for AML-1, Sox-5 and Snail within hPLSCR1 promoter.•−1118CAGGTG−1123 is the Snail binding site in hPLSCR1 promoter.•Interaction of Snail with endogenous hPLSCR1 promoter confirmed by ChIP assay. Human phospholipid scramblase 1 (hPLSCR1) is a proapoptotic protein whose expression is deregulated in a variety of cancers cells. However till date the transcription regulation of hPLSCR1 is unknown. Transcriptional regulation of hPLSCR1 was studied by cloning the 5′-flanking region of hPLSCR1. Luciferase assays revealed that −1525 to −1244 region of hPLSCR1 was found to regulate its promoter activity. A putative Snail transcription factor (TF) binding site was found within the regulatory region of the promoter. Snail binding was found to down regulate the expression of hPLSCR1 both at the transcriptional and translational levels. Snail knock down using Snail-shRNA confirmed that down regulation of hPLSCR1 by Snail was specific. Point mutation studies confirm that the predicted Snail TF binds to −1123 to −1117 site. ChIP assay further confirms the physical interaction of Snail with hPLSCR1 promoter. This is the first report showing the transcriptional regulation of hPLSCR1 expression by Snail TF and its possible implications in cancer progression.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2014.05.094